---
figid: PMC3989954__WJG-20-4178-g001
figtitle: Crosstalk between mechanistic target of rapamycin signaling pathway and
  colorectal oncogenic pathways
organisms:
- NA
pmcid: PMC3989954
filename: WJG-20-4178-g001.jpg
figlink: /pmc/articles/PMC3989954/figure/F1/
number: F1
caption: 'Crosstalk between mechanistic target of rapamycin signaling pathway and
  colorectal oncogenic pathways. PI3K/AKT and Ras/MAPK pathways are the major upstream
  mediators of mechanistic target of rapamycin (mTOR) signaling pathway in colorectal
  cancer. Therapeutic efforts for colorectal cancer targeting mTOR signaling include
  Rapamycin (or Rapalogs) inhibition as well as mTOR kinase inhibition, plus in combination
  with blockage of growth factor receptors, and components in upstream pathways such
  as Raf and PI3K, etc. New players regulating the mTOR pathway such as non-steroidal
  anti-inflammatory drug (NSAIDs) and metformin merit further investigation. IGF:
  Insulin like growth factor; SGK1: Serum- and glucocorticoid-induced protein kinase;
  PRAS40: Proline-rich Akt substrate 40 kDa; TSC1: Tuberous sclerosis-1; TSC2: Tuberous
  sclerosis-2; AMPK: Adenosine monophosphate-activated protein kinase; eIF4E: Eukaryotic
  translation initiation factor 4E; RSK1: Ribosomal S6 kinase.'
papertitle: Targeting mTOR network in colorectal cancer therapy.
reftext: Xiao-Wen Wang, et al. World J Gastroenterol. 2014 Apr 21;20(15):4178-4188.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9424475
figid_alias: PMC3989954__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3989954__F1
ndex: 26ccf669-defd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3989954__WJG-20-4178-g001.html
  '@type': Dataset
  description: 'Crosstalk between mechanistic target of rapamycin signaling pathway
    and colorectal oncogenic pathways. PI3K/AKT and Ras/MAPK pathways are the major
    upstream mediators of mechanistic target of rapamycin (mTOR) signaling pathway
    in colorectal cancer. Therapeutic efforts for colorectal cancer targeting mTOR
    signaling include Rapamycin (or Rapalogs) inhibition as well as mTOR kinase inhibition,
    plus in combination with blockage of growth factor receptors, and components in
    upstream pathways such as Raf and PI3K, etc. New players regulating the mTOR pathway
    such as non-steroidal anti-inflammatory drug (NSAIDs) and metformin merit further
    investigation. IGF: Insulin like growth factor; SGK1: Serum- and glucocorticoid-induced
    protein kinase; PRAS40: Proline-rich Akt substrate 40 kDa; TSC1: Tuberous sclerosis-1;
    TSC2: Tuberous sclerosis-2; AMPK: Adenosine monophosphate-activated protein kinase;
    eIF4E: Eukaryotic translation initiation factor 4E; RSK1: Ribosomal S6 kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pvr
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - IRSp53
  - IleRS
  - chico
  - Raf
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - p53
  - betaTub60D
  - hth
  - rl
  - Pten
  - Mtor
  - Tor
  - tor
  - Lkb1
  - Tsc1
  - gig
  - Pdk1
  - SNF4Agamma
  - AMPKalpha
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - Fkbp12
  - Rheb
  - Akt
  - PRAS40
  - SREBP
  - Crtc
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Rac1
  - Rac2
  - Mtl
  - S6k
  - Atg13
  - Thor
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - KDR
  - FLT1
  - FLT4
  - IGFBP3
  - IGF1
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K1
  - MAP2K2
  - RPS6KA1
  - TP53
  - TP63
  - TP73
  - MAPK3
  - MAPK1
  - PTEN
  - MTOR
  - RORC
  - STK11
  - TSC1
  - CCL26
  - TSC2
  - PDK1
  - PDPK1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - SGK1
  - DDIT4
  - FKBP1A
  - FKBP1AP1
  - FKBP1AP2
  - FKBP1AP3
  - FKBP1AP4
  - RHEB
  - RHEBP1
  - AKT1
  - AKT2
  - AKT3
  - AKT1S1
  - MAPKAP1
  - RICTOR
  - MLST8
  - SREBF1
  - RPTOR
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - RPS6KB1
  - RPS6KB2
  - PRKCA
  - ATG13
  - EIF4EBP1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
